{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:22:56Z","timestamp":1777598576266,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","award":["D108-F2507"],"award-info":[{"award-number":["D108-F2507"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007750","name":"National Cheng Kung University","doi-asserted-by":"publisher","award":["NCKUH-10709001"],"award-info":[{"award-number":["NCKUH-10709001"]}],"id":[{"id":"10.13039\/501100007750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007750","name":"National Cheng Kung University","doi-asserted-by":"publisher","award":["D107-F2519"],"award-info":[{"award-number":["D107-F2519"]}],"id":[{"id":"10.13039\/501100007750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007750","name":"National Cheng Kung University","doi-asserted-by":"publisher","award":["D106-35A13"],"award-info":[{"award-number":["D106-35A13"]}],"id":[{"id":"10.13039\/501100007750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ejphar.2020.173141","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T15:01:41Z","timestamp":1587999701000},"page":"173141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effectiveness in the inhibition of dapagliflozin and canagliflozin on M-type K+ current and \u03b1-methylglucoside-induced current in pituitary tumor (GH3) and pheochromocytoma PC12 cells"],"prefix":"10.1016","volume":"879","author":[{"given":"Edmund Cheung","family":"So","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Yen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173141_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cbi.2016.08.016","article-title":"Effect of canagliflozin and metformin on cortical neurotransmitters in a diabetic rat model","volume":"258","author":"Arafa","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2020.173141_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00232-002-1066-9","article-title":"Kinetic mechanism of Na+ -glucose cotransport through the rabbit intestinal SGLT1 protein","volume":"192","author":"Berteloot","year":"2003","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.ejphar.2020.173141_bib3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1055\/s-0043-106050","article-title":"Natural products as lead compounds for sodium glucose cotransporter (SGLT) inhibitors","volume":"83","author":"Blaschek","year":"2017","journal-title":"Planta Med."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2020.173141_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/dom.13749","article-title":"Sodium-glucose co-transporter inhibitors as adjunctive treatment to insulin in type 1 diabetes: a review of randomized controlled trials","volume":"21","author":"Boeder","year":"2019","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.ejphar.2020.173141_bib5","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1476-5381.2011.01466.x","article-title":"Facilitation of transmitter release from rat sympathetic neurons via presynaptic P2Y(1) receptors","volume":"164","author":"Chandaka","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173141_bib6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrd3180","article-title":"SGLT2 inhibition--a novel strategy for diabetes treatment","volume":"9","author":"Chao","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2020.173141_bib7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3389\/fphar.2018.00977","article-title":"Pioglitazone, a PPAR-gamma activator, stimulates BKCa but suppresses Ik M in hippocampal neurons","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173141_bib8","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1185\/03007995.2015.1069739","article-title":"Sodium glucose co-transporter inhibitors for the management of diabetes mellitus: an opinion paper from the endocrine and metabolism practice and research network of the American College of clinical pharmacy","volume":"31","author":"Clements","year":"2015","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejphar.2020.173141_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/tra.12042","article-title":"Trafficking of the IKs -complex in MDCK cells: site of subunit assembly and determinants of polarized localization","volume":"14","author":"David","year":"2013","journal-title":"Traffic"},{"key":"10.1016\/j.ejphar.2020.173141_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/1479164118783756","article-title":"Effects of sodium glucose co-transporter 2 inhibitors on the kidney","volume":"15","author":"de Albuquerque Rocha","year":"2018","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"10.1016\/j.ejphar.2020.173141_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2014.09.018","article-title":"Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin","volume":"224","author":"De Jonghe","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2020.173141_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00232-008-9143-3","article-title":"Involvement of amino acid 36 in TM1 in voltage sensitivity in mouse Na+\/glucose cotransporter SGLT1","volume":"227","author":"Diez-Sampedro","year":"2009","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.ejphar.2020.173141_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12883-018-1086-4","article-title":"Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy","volume":"18","author":"Erdogan","year":"2018","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ejphar.2020.173141_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00424-010-0890-5","article-title":"Hypothyroidism of gene-targeted mice lacking Kcnq1","volume":"461","author":"Frohlich","year":"2011","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.ejphar.2020.173141_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s13300-015-0117-z","article-title":"Efficacy and safety of canagliflozin used in conjunction with sulfonylurea in patients with type 2 diabetes mellitus: a randomized, controlled trial","volume":"6","author":"Fulcher","year":"2015","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.ejphar.2020.173141_bib16","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2337\/db07-1472","article-title":"Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats","volume":"57","author":"Han","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2020.173141_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s002329900169","article-title":"Presteady-state currents of the rabbit Na+\/glucose cotransporter (SGLT1)","volume":"155","author":"Hazama","year":"1997","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.ejphar.2020.173141_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainresbull.2019.03.016","article-title":"Concerted suppression of Ih and activation of Ik(M) by ivabradine, an HCN-channel inhibitor, in pituitary cells and hippocampal neurons","volume":"149","author":"Hsiao","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2020.173141_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2010.10.010","article-title":"Inhibitory action of methadone and its metabolites on erg-mediated K+ current in GH(3) pituitary tumor cells","volume":"280","author":"Huang","year":"2011","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2020.173141_bib20","doi-asserted-by":"crossref","first-page":"C14","DOI":"10.1152\/ajpcell.00388.2010","article-title":"Glucose transport by human renal Na+\/D-glucose cotransporters SGLT1 and SGLT2","volume":"300","author":"Hummel","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejphar.2020.173141_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00424-018-2208-y","article-title":"Involvement of butyrate in electrogenic K(+) secretion in rat rectal colon","volume":"471","author":"Inagaki","year":"2019","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.ejphar.2020.173141_bib22","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbrc.2006.01.046","article-title":"The corticosteroid hormone induced factor: a new modulator of KCNQ1 channels?","volume":"341","author":"Jespersen","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2020.173141_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2018.08.054","article-title":"Euglisemic diabetic ketoacidotic coma caused by dapagliflozin","volume":"36","author":"Karakaya","year":"2018","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.ejphar.2020.173141_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11060-018-2823-7","article-title":"Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas","volume":"138","author":"Kepe","year":"2018","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.ejphar.2020.173141_bib25","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1053\/gast.2001.29567","article-title":"D-glucose releases 5-hydroxytryptamine from human BON cells as a model of enterochromaffin cells","volume":"121","author":"Kim","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2020.173141_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/clpt.2008.250","article-title":"Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus","volume":"85","author":"Komoroski","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2020.173141_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s002320010045","article-title":"Cloning and function of the rat colonic epithelial K+ channel KVLQT1","volume":"179","author":"Kunzelmann","year":"2001","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.ejphar.2020.173141_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1124\/jpet.114.217992","article-title":"Analysis of the effect of canagliflozin on renal glucose reabsorption and progression of hyperglycemia in zucker diabetic Fatty rats","volume":"351","author":"Kuriyama","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173141_bib29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000074447","article-title":"Role of K(+) channels in frequency regulation of spontaneous action potentials in rat pituitary GH(3) cells","volume":"78","author":"Lee","year":"2003","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ejphar.2020.173141_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00210-008-0353-0","article-title":"Tramadol-induced block of hyperpolarization-activated cation current in rat pituitary lactotrophs","volume":"379","author":"Liu","year":"2009","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173141_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejphar.2018.12.005","article-title":"Parecoxib, a selective blocker of cyclooxygenase-2, directly inhibits neuronal delayed-rectifier K(+) current, M-type K(+) current and Na(+) current","volume":"844","author":"Liu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173141_bib32","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1073\/pnas.90.12.5767","article-title":"Relaxation kinetics of the Na+\/glucose cotransporter","volume":"90","author":"Loo","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2020.173141_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fphar.2019.00076","article-title":"Evidence for effective multiple K(+)-Current inhibitions by tolvaptan, a non-peptide antagonist of vasopressin V2 receptor","volume":"10","author":"Lu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173141_bib34","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1523\/JNEUROSCI.3143-03.2004","article-title":"M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals","volume":"24","author":"Martire","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173141_bib35","doi-asserted-by":"crossref","first-page":"854","DOI":"10.4239\/wjd.v5.i6.854","article-title":"Place of sodium-glucose co-transporter type 2 inhibitors for treatment of type 2 diabetes","volume":"5","author":"Mikhail","year":"2014","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.ejphar.2020.173141_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4137\/CMED.S18182","article-title":"A clinical perspective of canagliflozin in the management of type 2 diabetes mellitus","volume":"7","author":"Nardolillo","year":"2014","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"key":"10.1016\/j.ejphar.2020.173141_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2016.11.028","article-title":"Canagliflozin, a sodium glucose cotransporter 2 inhibitor, attenuates obesity-induced inflammation in the nodose ganglion, hypothalamus, and skeletal muscle of mice","volume":"794","author":"Naznin","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173141_bib38","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1021\/jm100332n","article-title":"Discovery of canagliflozin, a novel C-glucoside with thiophene ring, as sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus","volume":"53","author":"Nomura","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173141_bib39","doi-asserted-by":"crossref","first-page":"27099","DOI":"10.1074\/jbc.270.45.27099","article-title":"Kinetics of steady-state currents and charge movements associated with the rat Na+\/glucose cotransporter","volume":"270","author":"Panayotova-Heiermann","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173141_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF00235797","article-title":"Electrogenic properties of the cloned Na+\/glucose cotransporter: I. Voltage-clamp studies","volume":"125","author":"Parent","year":"1992","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.ejphar.2020.173141_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1871529X18666180206123149","article-title":"Sodium-glucose cotransporter 2 inhibitors and the risk of diabetic ketoacidosis; from pathophysiology to clinical practice","volume":"18","author":"Patoulias","year":"2018","journal-title":"Cardiovasc. Haematol. Disord. - Drug Targets"},{"key":"10.1016\/j.ejphar.2020.173141_bib42","doi-asserted-by":"crossref","first-page":"31214","DOI":"10.1038\/srep31214","article-title":"Dapagliflozin stimulates glucagon secretion at high glucose: experiments and mathematical simulations of human A-cells","volume":"6","author":"Pedersen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173141_bib43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/cpdd.115","article-title":"Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on C-peptide kinetics","volume":"4","author":"Polidori","year":"2015","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.ejphar.2020.173141_bib44","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/dom.12684","article-title":"Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin","volume":"18","author":"Rodbard","year":"2016","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.ejphar.2020.173141_bib45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2337\/dc15-1736","article-title":"Initial combination therapy with canagliflozin plus metformin versus each component as monotherapy for drug-naive type 2 diabetes","volume":"39","author":"Rosenstock","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2020.173141_bib46","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1463-1326.2011.01406.x","article-title":"Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects","volume":"13","author":"Sha","year":"2011","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.ejphar.2020.173141_bib47","doi-asserted-by":"crossref","first-page":"C234","DOI":"10.1152\/ajpcell.1990.258.2.C234","article-title":"Whole cell recording of sugar-induced currents in LLC-PK1 cells","volume":"258","author":"Smith-Maxwell","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2020.173141_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030657","article-title":"Bisoprolol, known to Be a selective beta(1)-receptor antagonist, differentially but directly suppresses Ik(M) and Ik(erg) in pituitary cells and hippocampal neurons","volume":"20","author":"So","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2020.173141_bib49","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.toxlet.2018.01.002","article-title":"Differential regulation of tefluthrin and telmisartan on the gating charges of INa activation and inactivation as well as on resurgent and persistent INa in a pituitary cell line (GH3)","volume":"285","author":"So","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejphar.2020.173141_bib50","doi-asserted-by":"crossref","first-page":"H2597","DOI":"10.1152\/ajpheart.00393.2006","article-title":"Electrophysiological mechanisms of ventricular arrhythmias in relation to Andersen-Tawil syndrome under conditions of reduced Ik1: a simulation study","volume":"291","author":"Sung","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2020.173141_bib51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13300-010-0007-3","article-title":"Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes","volume":"1","author":"Tahrani","year":"2010","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.ejphar.2020.173141_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1113\/jphysiol.2006.111336","article-title":"Kv7\/KCNQ\/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release","volume":"576","author":"Vervaeke","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2020.173141_bib53","first-page":"15","article-title":"Simulations of the cardiac action potential based on the Hodgkin-Huxley kinetics with the use of Microsoft Excel spreadsheets","volume":"47","author":"Wu","year":"2004","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.ejphar.2020.173141_bib54","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1002\/jcp.25788","article-title":"Stimulatory actions of a novel thiourea derivative on large-conductance, calcium-activated potassium channels","volume":"232","author":"Wu","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2020.173141_bib55","first-page":"148403","article-title":"Evidence for inhibitory effects of flupirtine, a centrally acting analgesic, on delayed rectifier k(+) currents in motor neuron-like cells","author":"Wu","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.ejphar.2020.173141_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tox.2009.01.009","article-title":"Underlying mechanism of actions of tefluthrin, a pyrethroid insecticide, on voltage-gated ion currents and on action currents in pituitary tumor (GH3) cells and GnRH-secreting (GT1-7) neurons","volume":"258","author":"Wu","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2020.173141_bib57","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2826.2000.00447.x","article-title":"Expression of mRNA for voltage-dependent and inward-rectifying K channels in GH3\/B6 cells and rat pituitary","volume":"12","author":"Wulfsen","year":"2000","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2020.173141_bib58","first-page":"7074868","article-title":"Newer perspectives of mechanisms for euglycemic diabetic ketoacidosis","volume":"2018","author":"Yu","year":"2018","journal-title":"Internet J. Endocrinol."},{"key":"10.1016\/j.ejphar.2020.173141_bib59","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1124\/mol.105.014035","article-title":"Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity","volume":"68","author":"Zhou","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173141_bib60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuropharm.2016.11.024","article-title":"Acute stress diminishes M-current contributing to elevated activity of hypothalamic-pituitary-adrenal axis","volume":"114","author":"Zhou","year":"2017","journal-title":"Neuropharmacology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920302338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920302338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:27:39Z","timestamp":1777393659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920302338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":60,"alternative-id":["S0014299920302338"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173141","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness in the inhibition of dapagliflozin and canagliflozin on M-type K+ current and \u03b1-methylglucoside-induced current in pituitary tumor (GH3) and pheochromocytoma PC12 cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173141"}}